By corollary, effective therapeutics that mitigate depressive-related symptoms (e.g., antidepressants and physical activity) will optimize BDNF in key brain regions to promote neuronal health and recovery of function in MDD-related circuits. The gene discussed is BDNF; the disease is major depressive disorder.